Laboratorios Farma | ROVI - 债务利息支出

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.13B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	债务利息支出	更改		日
Akebia Therapeutics	349.66M		12.86M	2026-06
Alaunos Therapeutics	USD 1.07M		215K	2023-06
Avita Medical	AUD 1.25M		100K	2025-06
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Ionis Pharmaceuticals	USD 18M		1000K	2026-06
IQVIA Holdings	USD 197M		5M	2026-06
Laboratorios Farma	EUR 699K		666.2K	2025-06
Moderna	USD 10.96B		527M	2026-06
Organon & Co	USD 108M		3M	2026-06
Pharma Mar	EUR 117K		1.24M	2025-09
Revvity	USD 22.99M		1.73M	2026-06
Tectonic Therapeutic	USD 246.58M		246.56M	2026-03
Viatris	USD 120.7M		600K	2026-06
Xeris Pharmaceuticals	USD 6.88M		269K	2026-03